SUBCUTANEOUS(S.C.) LOW DOSE RIL-2 IN ADDITION TO 5-FU AND LV INCREASIS THE RESPONSE RATE(RR) AND DURATION OF RESPONSE OF METASTATIC COLORECTAL CANCER PATIENTS(PTS.): A PILOT STUDY WITH A MULTISTEP THERAPY.